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INTRODUCTION
An intravascular (or intravenous) leiomyoma is a histo-
logically benign tumor characterized by the proliferation of
smooth muscle cells arising from the intrauterine venules
and/or the myometrium (1-4); however, exceptional cases
that arise from cutaneous vessels and pelvic or retro-
peritoneal veins have been found (5,6). This tumor affects
only women, particularly middle-aged women (median age,
44 years) with a history of hysterectomy (4). Usually, an
intravascular leiomyoma enters through the lumen of the
iliac veins and grows into the inferior vena cava, sometimes
reaching the right heart chambers (1-4,7-10). In this
situation, one- or two-stage surgery has been used to
prevent fatal complications (e.g., total tricuspid obstruction)
(3,4,9-13).
Here, we report the case of a 34-year-old totally
asymptomatic woman with a history of uterine myoma
and with evidence of a pelvic intracaval mass extending to
the right atrium. The patient was treated with a one-stage
surgical protocol that combined cardiac and vascular
procedures in a thoracoabdominal approach under cardio-
pulmonary bypass at 32 C˚. The histological analysis of the
excised specimen was consistent with an intravascular
leiomyoma. The more recent findings on the pathogenesis,
incidence, clinical presentation, diagnosis, and treat-
ment of intravascular leiomyo are discussed in this
communication.
CASE REPORT
The patient was a 34-year-old nulliparous woman who
was admitted to our cardiovascular center in July 2009.
According to her medical history, she underwent a
myomectomy in 2002. Seven years later, in 2008, the patient
presented with a recurrence of the myoma. A hysterectomy
was attempted but was unsuccessful due to adhesions from
the previous surgery. During the course of the procedure,
the surgeon had (inadvertently) ligated the ureter, and the
patient had developed a vesicoureteral fistula.
Upon admission, the patient was completely without
cardio-respiratory symptoms. Her vital signs were as
follows: heart rate of 77 beats/minute; blood pressure of
140/80 mmHg; respiratory rate of 15 breaths/minute; and
temperature of 36.2 C˚. The physical examination revealed a
hard and painless abdominal mass extending from the
hypogastric region to the right flank. There were no signs
of venous hypertension in the lower extremities, such as
lipodermatosclerosis, edema, or hyperpigmentation. The
routine laboratory examinations of the blood and the urine
were normal.
A thoracoabdominal computed tomography scan
(Figure 1A) revealed a mass extending from the right
internal iliac vein to the right atrium; however, it was
unclear whether this mass represented a thrombus or a
tumor. Multiple cysts were observed in both kidneys
(Figure 1A-4). The inferior vena cava was severely dilated
(11 cm) (Figure 1A-5). Transesophageal echocardiography
revealed a hyperechoic and mobile mass that filled 2/3 of
the right atrium and protruded across the tricuspid valve
throughout the cardiac cycle. Owing to the high risk of
severe complications and death, a one-stage surgical
strategy that combined cardiac and vascular procedures
was planned to remove the mass. It should be mentioned
that 28 days prior to the cardiovascular surgery, the patient
underwent a total hysterectomy with bilateral salpingo-
oophorectomy and resection of the vesical dome due to the
previously mentioned adhesions. The right internal iliac
vein was ligated with the mass inside, and the vesicour-
eteral fistula was repaired.
The removal of the intracardiac and intravascular masses
was performed on October 30, 2009. The superior and
inferior vena cava, the right atrium, and the two renal, iliac,
and suprahepatic veins were exposed via a right thoraco-
phrenolaparotomy in the fifth intercostal space (Figure 2A),
after which the pericardium was opened with an inverted T-
shaped incision (Figure 2B). Cardiopulmonary bypass was
established by cannulating the ascending aorta, with venous
drainage through the right atrium and the superior vena
cava. Myocardial protection was provided by retrograde
isothermic blood (32 C˚). The superior and inferior vena cava
were longitudinally incised for exposure and complete
eradication of the mass. In the first step, the intra-atrial
extension of the mass was removed through a superior vena
cava incision located 3 cm proximal to the closed right
atrium (Figure 2C). An atriotomy was not performed
because we were able to confirm beforehand that the
intracardiac tumor was mobile and could be drawn out of
the closed atrium without complications. In the second step,
the intravascular extension of the mass was detached and
removed through an inferior cava venotomy (Figure 2D)
that extended caudally towards the iliac bifurcation. The
excised mass measured approximately 31 cm in length
(Figure 2E) and had no thrombi or areas of friable tissue.
The histological examination revealed a benign tumor
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compatible with an intravascular leiomyoma (Figure 2F).
There were no extensive hyaline zones obscuring the
underlying smooth muscle nature of the tumor, and
complementary studies with myogenic markers (alpha-
smooth muscle actin and desmin) were not required. All
of the neoplastic cells were positive for progesterone and
negative for estrogen.
At the end of the procedure, the suprahepatic segment of
the inferior vena cava was repaired and clamped just above
the liver. Next, the venous clamp was moved along the
infrahepatic segment of the vessel, which was repaired
towards the iliac bifurcation. The heart beat was restored,
and the cardiopulmonary bypass was discontinued without
complications. The total cardiopulmonary bypass time was
42 minutes, and the patient experienced no hemodynamic
alterations after the procedure.
The postoperative course was uneventful, and a control
computed tomography scan revealed no evidence of tumor
(Figure 1B-H). The patient was discharged from our service
on postoperative day six with a 15-day prescription for
Figure 1 - (A) A preoperative sagittal computed tomography (CT) scan showing a mass (leiomyoma) extending from the right internal
iliac vein to the right atrium. Figures A-1 to A-7 show the transverse CT scans of the areas indicated in A. (A-1 and A-2) The intracardiac
tumor. (A-3 to A-4) The intracaval tumor. Note that both kidneys presented with multiple cysts. (A-5) The severely dilated inferior vena
cava (11 cm). (A-6) The multilobulated pelvic tumor with intense vascularization. (A-7) The intrailiac tumor. (B-H) The postoperative CT
scans, showing absence of the tumor and a normal-diameter inferior vena cava. I-HVC, intrahepatic vena cava; IVC, inferior vena cava;
RA, right atrium; RHC, right heart chambers; RV, right ventricle; yellow arrow, tumor localization; black arrow, vessel lumen.
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low-molecular-weight-heparin (enoxaparin), to be followed
by anti-vitamin K and tamoxifen (200 mg) for six months.
The patient presented without any complications at 14
months postoperatively (the most recent consultation).
DISCUSSION
An intravascular leiomyoma is an insidious tumor, and
extension into the right heart chambers can occur slowly,
over many years (2-4,7-10). Our PubMed and Cochrane
library literature search retrieved only 132 cases of
leiomyoma with heart extension, many of which (,40%)
have been described over the last 15 years. It is probable that
recent advances in tumor diagnosis imaging and immuno-
chemistry have resulted in an increased number of reports
by facilitating the distinguishment between intravascular
leiomyoma and other similar disorders, especially thrombi
and malignant tumors (8). In addition, it is possible that the
incidence of intravascular leiomyo is rising due to increased
risk factors for developing hormone-dependent tumors (14).
In general, intravascular leiomyomata affect premenopausal
women, and the majority (¡90%) are parous (4). (our
patient was exceptional in being nulliparous).
The recent literature has recommended that an intravas-
cular leiomyoma diagnosis be considered in all women
presenting with deep vein thrombosis, a contrast-enhancing
mass (visualized by computed tomography scan) within the
vena cava or the right atrium, and unspecific symptoms
associated with a history of pelvic surgery, hysterectomy, or
uterine leiomyomatosis (15). A definitive intravascular
leiomyoma diagnosis is confirmed by a histopathological
analysis. A physical examination and adequate diagnostic
imaging can rule out other potential diagnoses, allowing the
physician to refer the patient for correct treatment.
Nonetheless, the differential diagnosis between thrombus-
in-transit and intravascular leiomyoma is not always clear by
echocardiography or other imaging. In general, the features
suggestive of a thrombus-in-transit include postoperative
status, indwelling intravascular devices, immobility com-
bined with other thromboembolism risk factors, and elon-
gated mobile masses of a venous cast that have a ‘‘popcorn’’
appearance (16). By contrast, the classical appearance of an
intravascular leiomyoma is an elongated mobile mass
extending from the veins of the lower body, including the
inferior vena cava and the azygos vein, that fills the vessel
lumen and the right heart chambers and has multiple venous
attachments (especially at the origin of tumor) (15-17).
The molecular mechanisms associated with the pheno-
typic and behavioral characteristics of an intravascular
leiomyoma are not completely defined. There is evidence
that hyaluronan, a non-sulfated proteoglycan from the
extracellular matrix synthesized within the leiomyoma,
can play a modulatory role in the kinetics of cell prolifera-
tion and the growth rate of the tumor (18,19). Recently,
significant evidence has suggested a close relationship
between intravascular and uterine leiomyomata. The neo-
plastic smooth muscle of an intravenous leiomyoma
resembles that of a benign uterine leiomyoma and may
include the same histological variants found in the uterus
(5). Furthermore, both leiomyomata are genetically char-
acterized by a balanced t translocation (12,14). involving
the chromatin remodeling-gene HMGA2 (20,21). The
contribution of HMGA2 to the intravascular leiomyoma
phenotype remains under investigation.
Figure 2 - (A) The right atrium and the superior and inferior vena cava were completely exposed through a right
thoracophrenolaparotomy. (B) The pericardium was opened to access and cannulate the right atrium. (C) The intra-atrial extension
of the tumor was removed through a superior cava incision located 3 cm proximal to the atrium. Note that the right atrium was not
opened to achieve tumor exposure. (D) The intracaval extension of the tumor was completely detached from the vessel wall. (E) The
specimen morphology. The excised tumor measured 31 cm in length and had no thrombi or areas of friable tissue. (F) A histological
examination of a hematoxylin and eosin-stained tissue section (200X). The smooth muscle cells were predominantly organized into
fascicles and occasionally into a plexiform pattern. The cells showed no abnormal mitotic activity, atypia, or necrosis, supporting the
diagnosis of intravascular leiomyoma. IVC, inferior vena cava; RA, right atrium; RK, right kidney; SVC, superior vena cava.
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Although it is nonmalignant, an intracardiac leiomyoma
can lead to severe complications, including obstruction of
the tricuspid valve, valvular regurgitation and diminished
cardiac performance to the point of overt heart failure
(7,15,22). Rarely, this tumor coincides with a benign
metastasizing leiomyoma in the lung (5,23). A few cases of
obstructive shock and sudden deaths have been reported in
literature (5,24,25).
Since 1982, two surgical procedures have been performed
to treat intravascular leiomyo with heart extension (3,4,9-
13). The first requires completely removing the intracardiac
and intracaval mass through a one-stage surgical approach,
as in our case (3,4). The second involves an abdominal stage
and a thoracic stage (11,12). The specific indications for each
procedure are unclear and depend on the surgeon’s
experience and the preoperative status of the patient.
In many centers, including our own, one-stage surgery
is the preferred operation for treating tumors with heart
extension in patients with a clear preoperative diagnosis,
good health conditions, and/or normal operative risks (3).
By contrast, two-stage surgeries are typically planned for
high-risk patients, including those with cardiopulmonary
comorbidities, risk factors for major bleeding, and compli-
cations requiring repairing or resectioning the thoracic and
abdominal structures; in the latter case, a one-stage surgery
could result in a much longer operative time (3,10).
There are no guidelines for performing one-stage versus
two-stage surgeries (13). Different surgical protocols have
been applied to leiomyomata. For example, when planning a
two-stage surgical protocol, no consensus exists on which
component of the operation (abdominal or thoracic) should
be performed first. In our opinion, the abdominal component
should be performed before the thoracic due to the likelihood
of encountering a dense adherence to the vascular wall at the
origin of the tumor (by contrast, adherences along the upper
path are often loose or nonexistent).
Regarding one-stage surgery techniques, our protocol
consisted of the following specific features: 1) Surgical
access was achieved through a right thoracophrenolapar-
otomy (single incision) rather than a median sternotomy
plus laparotomy (two separate incisions), which has been
used in several previous reports. Although unusual, our
approach offered excellent exposure of the ascending
aorta, the atrium, and the vena cava and its tributaries.
2) The right atrium was not opened to expose the
intracardiac extension of the leiomyoma because we had
previously confirmed that it was mobile and free from
adhesions. When the tumor presents with cardiac adher-
ences and compromises the morphofunctional integrity of
the heart valves, an atriotomy is mandatory. 3) The
cardiopulmonary bypass was established by cannulating
the ascending aorta, with venous drainage through the
right atrium and the superior vena cava. By contrast, some
surgeons have opted for cannulating the right subclavian
artery and the right femoral vein (3). 4) Myocardial
protection was provided by retrograde isothermic blood
rather than deep hypothermia, which has been used in
previous reports. Recent studies have demonstrated that
the isothermic approach used here provides more physio-
logical myocardial metabolic activity than the hypothermic
approach (i.e., the myocardium utilizes more oxygen and
more glucose while producing less lactate) (26-28). We
think that isothermia provides the same clinical benefits
and eliminates the possible adverse effects of deep
hypothermia and total circulatory arrest.
It is worth noting that surgically treating intravascular
leiomyo with heart extension has a favorable prognosis.
However, tumor recurrence can occur up to 15 years after
the surgery. To prevent this complication, many authors,
including our group, have recommended postoperative
hormonal therapy with antiestrogens or aromatase-inhibi-
tors, such as tamoxifen (23,29).
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